updat fcf-per-share spin-off transact
stitch togeth opportun use anthracyclin treat
quick read underli trend solid
quick read indic ep mislead
analyst certif import disclosur see
updat fcf-per-share spin-off transact
increas target maintain outperform rate base posit impact
agre tax-fre spin-off result deal believ fcf-per-share abil grow y/i
base mid-teen ebitda growth rais fcf-per-share estim respect
believ acquir nol provid materi tax benefit assum target net debt ebitda lastli
think posit market reaction function fair clean deal term clariti around time target
assum p/fcf ev/ebitda in-lin multipl peer wix
stitch togeth opportun use anthracyclin treat lung met
mbrx recent provid two updat annamycin next-gener anthracyclin program collect provid
clear pictur potenti differenti drug class base potenti efficaci tumor type
anthracyclin current use lung cancer elimin cardiotox limit durat dose
doxorubicin specif view data present last week san antonio breast cancer meet demonstr annamycin
concentr lung tissu improv surviv murin lung met model intrigu find support
futur clinic studi could upsid peak sale forecast
quick read underli trend solid
yesterday market close outperform-r nike report nov result updat guidanc
may indic larger impact tariff shift market spend later year muddl
announc bit behind nois fundament momentum compani remain solidli place
constant currenc sale growth improv recommend client focu underli improv prowess
use weak share increment buy opportun
top stori week congress pass year-end domest spend packag favor healthcar
deal includ repeal three fee includ health insur fee hif provis prevent
sabotag administr addit long-await decis fifth circuit court releas
appear punt decis back lower court delay suprem court decis elect
note healthcar servic weekli publish next two week due holiday schedul return
week januari happi holiday new year
quick read indic ep mislead
earli today outperform-r announc nov result view initi indic earn
miss period larg mislead odd decidedli posit underli trend chain exclud
impact higher stock-bas compens nov ep would track vs report figur
street estim upon use car unit comp use car gross margin per unit gpu
modestli prior year recommend investor use weak share today buy
